Imatinib Tablets

The VA Enterprise Procurement Office plans to award one contract for Imatinib Mesylate Tablets for the VA and its listed programs, DoD and TRICARE mail-order pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Center; the term is one year plus four one-year options, with distribution through VA and DoD Pharmaceutical Prime Vendor Programs. The procurement is unrestricted, and offerors must provide an uninterrupted supply and identify the exact product-label name and a unique NDC; the contractor’s label must be the product’s only label and allow VA labels to adhere securely. Unit-of-use packaging for the listed 30- and 90-count bottles must have a convertible or deshellable safety cap and a bottle of at least 120 cc, with a cylindrical body, at least 5.75 inches in circumference, and space for a 5.25-by-2-inch label; one or more items are subject to WTO and Free Trade Agreement requirements.